PDS Biotechnology Corp Operating Cash Flow
PDS Biotechnology Corp (PDSB) reported Operating Cash Flow of -$7.16 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-13
- PDS Biotechnology Corp net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$2.79M.
- PDS Biotechnology Corp net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$4.37M.
- PDS Biotechnology Corp net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$3.70M.
- PDS Biotechnology Corp net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$5.92M.
- PDS Biotechnology Corp net cash provided by (used in) operating activities for fiscal 2025 was -$27.75M.
- PDS Biotechnology Corp net cash provided by (used in) operating activities for fiscal 2024 was -$35.03M.
- PDS Biotechnology Corp net cash provided by (used in) operating activities for fiscal 2023 was -$33.64M.
- PDS Biotechnology Corp net cash provided by (used in) operating activities for fiscal 2022 was -$25.71M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$2.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$7.16M 10-Q · filed 2026-08-13 | -$10.87M derived: sum of 3 quarters · filed 2026-08-13 | -$16.78M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | -$4.37M 10-Q · filed 2026-05-14 | -$8.07M derived: sum of 2 quarters · filed 2026-05-14 | -$13.99M derived: sum of 3 quarters · filed 2026-05-14 | -$23.09M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | -$3.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$9.62M derived: sum of 2 quarters · filed 2026-03-30 | -$18.72M derived: sum of 3 quarters · filed 2026-08-13 | -$27.75M 10-K · filed 2026-03-30 | ||||
| 2025-09-30 | -$5.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$15.02M derived: sum of 2 quarters · filed 2026-08-13 | -$24.05M 10-Q · filed 2025-11-13 | -$32.28M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | -$9.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$18.13M 10-Q · filed 2026-08-13 | -$26.37M derived: sum of 3 quarters · filed 2026-08-13 | -$34.37M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | -$9.03M 10-Q · filed 2026-05-14 | -$17.27M derived: sum of 2 quarters · filed 2026-05-14 | -$25.27M derived: sum of 3 quarters · filed 2026-05-14 | -$34.12M derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | -$8.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$16.23M derived: sum of 2 quarters · filed 2026-03-30 | -$25.09M derived: sum of 3 quarters · filed 2026-03-30 | -$35.03M 10-K · filed 2026-03-30 | ||||
| 2024-09-30 | -$8.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$16.86M derived: sum of 2 quarters · filed 2025-11-13 | -$26.80M 10-Q · filed 2025-11-13 | -$35.25M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | -$8.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$18.80M 10-Q · filed 2025-08-13 | -$27.25M derived: sum of 3 quarters · filed 2025-08-13 | -$34.43M derived: sum of 4 quarters · filed 2025-08-13 | ||||
| 2024-03-31 | -$9.94M 10-Q · filed 2025-05-14 | -$18.40M derived: sum of 2 quarters · filed 2025-05-14 | -$25.57M derived: sum of 3 quarters · filed 2025-05-14 | -$30.39M derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | -$8.46M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$15.63M derived: sum of 2 quarters · filed 2025-03-27 | -$20.45M derived: sum of 3 quarters · filed 2025-03-27 | -$33.64M 10-K · filed 2025-03-27 | ||||
| 2023-09-30 | -$7.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$11.99M derived: sum of 2 quarters · filed 2024-11-14 | -$25.18M 10-Q · filed 2024-11-14 | -$32.71M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | -$4.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$18.00M 10-Q · filed 2024-08-13 | -$25.53M derived: sum of 3 quarters · filed 2024-08-13 | -$31.42M derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | -$13.19M 10-Q · filed 2024-05-15 | -$20.72M derived: sum of 2 quarters · filed 2024-05-15 | -$26.61M derived: sum of 3 quarters · filed 2024-05-15 | -$32.53M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | -$7.53M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$13.42M derived: sum of 2 quarters · filed 2024-03-28 | -$19.34M derived: sum of 3 quarters · filed 2024-03-28 | -$25.71M 10-K · filed 2024-03-28 | ||||
| 2022-09-30 | -$5.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$11.81M derived: sum of 2 quarters · filed 2023-11-14 | -$18.18M 10-Q · filed 2023-11-14 | -$22.68M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | -$5.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$12.29M 10-Q · filed 2023-08-14 | -$16.79M derived: sum of 3 quarters · filed 2023-08-14 | -$21.92M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | -$6.37M 10-Q · filed 2023-05-15 | -$10.87M derived: sum of 2 quarters · filed 2023-05-15 | -$16.00M derived: sum of 3 quarters · filed 2023-05-15 | -$15.05M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | -$4.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | -$9.63M derived: sum of 2 quarters · filed 2023-03-28 | -$8.68M derived: sum of 3 quarters · filed 2023-03-28 | -$12.49M 10-K · filed 2023-03-28 | ||||
| 2021-09-30 | -$5.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$4.18M derived: sum of 2 quarters · filed 2022-11-14 | -$7.98M 10-Q · filed 2022-11-14 | -$12.61M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $946.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$2.86M 10-Q · filed 2022-08-08 | -$7.49M derived: sum of 3 quarters · filed 2022-08-08 | -$8.74M derived: sum of 4 quarters · filed 2022-08-08 | ||||
| 2021-03-31 | -$3.80M 10-Q · filed 2022-05-11 | -$8.43M derived: sum of 2 quarters · filed 2022-05-11 | -$9.68M derived: sum of 3 quarters · filed 2022-05-11 | -$13.79M derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2020-12-31 | -$4.63M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$5.88M derived: sum of 2 quarters · filed 2022-03-31 | -$9.98M derived: sum of 3 quarters · filed 2022-03-31 | -$13.15M 10-K · filed 2022-03-31 | ||||
| 2020-09-30 | -$1.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$5.36M derived: sum of 2 quarters · filed 2021-11-10 | -$8.52M 10-Q · filed 2021-11-10 | -$14.04M derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | -$4.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$7.27M 10-Q · filed 2021-08-12 | -$12.79M derived: sum of 3 quarters · filed 2021-08-12 | -$17.12M derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | -$3.16M 10-Q · filed 2021-05-13 | -$8.68M derived: sum of 2 quarters · filed 2021-05-13 | -$13.01M derived: sum of 3 quarters · filed 2021-05-13 | -$17.87M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | -$5.52M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | -$9.85M derived: sum of 2 quarters · filed 2021-03-18 | -$14.71M derived: sum of 3 quarters · filed 2021-03-18 | -$18.07M 10-K · filed 2021-03-18 | ||||
| 2019-09-30 | -$4.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | -$9.19M derived: sum of 2 quarters · filed 2020-11-13 | -$12.55M 10-Q · filed 2020-11-13 | -$12.87M derived: sum of 4 quarters · filed 2020-11-13 | ||||
| 2019-06-30 | -$4.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | -$8.23M 10-Q · filed 2020-08-13 | -$8.54M derived: sum of 3 quarters · filed 2020-08-13 | -$8.98M derived: sum of 4 quarters · filed 2020-08-13 | ||||
| 2019-03-31 | -$3.37M 10-Q · filed 2020-05-13 | -$3.68M derived: sum of 2 quarters · filed 2020-05-13 | -$4.12M derived: sum of 3 quarters · filed 2020-05-13 | -$4.53M derived: sum of 4 quarters · filed 2020-05-13 | ||||
| 2018-12-31 | -$317.63K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | -$749.87K derived: sum of 2 quarters · filed 2020-03-27 | -$1.17M derived: sum of 3 quarters · filed 2020-03-27 | -$1.57M 10-K · filed 2020-03-27 | -$33.15M 10-K · filed 2019-02-21 | |||
| 2018-09-30 | -$432.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$847.61K derived: sum of 2 quarters · filed 2019-11-07 | -$1.25M 10-Q · filed 2019-11-07 | -$30.98M 10-Q · filed 2018-11-01 | -$10.49M derived: sum of 4 quarters · filed 2019-11-07 | |||
| 2018-06-30 | -$415.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$819.70K 10-Q · filed 2019-08-01 | -$21.82M 10-Q · filed 2018-08-01 | -$10.06M derived: sum of 3 quarters · filed 2019-08-01 | -$21.46M derived: sum of 4 quarters · filed 2019-08-01 | |||
| 2018-03-31 | -$404.34K 10-Q · filed 2019-05-14 | -$13.70M 10-Q · filed 2018-05-01 | -$9.64M derived: sum of 2 quarters · filed 2019-05-14 | -$21.04M derived: sum of 3 quarters · filed 2019-05-14 | -$30.33M derived: sum of 4 quarters · filed 2019-05-14 | |||
| 2017-12-31 | -$9.24M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | -$20.64M derived: sum of 2 quarters · filed 2019-02-21 | -$29.92M derived: sum of 3 quarters · filed 2019-02-21 | -$40.70M 10-K · filed 2019-02-21 | ||||
| 2017-09-30 | -$11.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | -$20.68M derived: sum of 2 quarters · filed 2018-11-01 | -$31.46M 10-Q · filed 2018-11-01 | -$37.50M derived: sum of 4 quarters · filed 2018-11-01 | ||||
| 2017-06-30 | -$9.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | -$20.06M 10-Q · filed 2018-08-01 | -$26.10M derived: sum of 3 quarters · filed 2018-08-01 | -$34.90M derived: sum of 4 quarters · filed 2018-08-01 | ||||
| 2017-03-31 | -$10.77M 10-Q · filed 2018-05-01 | -$16.82M derived: sum of 2 quarters · filed 2018-05-01 | -$25.61M derived: sum of 3 quarters · filed 2018-05-01 | |||||
| 2016-12-31 | -$6.05M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | -$14.84M derived: sum of 2 quarters · filed 2018-03-01 | -$32.19M 10-K · filed 2018-03-01 | |||||
| 2016-09-30 | -$8.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | -$26.14M 10-Q · filed 2017-11-01 | ||||||
| 2016-06-30 | -$17.35M 10-Q · filed 2017-08-01 | |||||||
| 2015-12-31 | -$21.75M 10-K · filed 2018-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |